|
Volumn 2, Issue 4, 2012, Pages 213-225
|
Processing and sustained in vitro release of rifampicin containing composites to enhance the treatment of osteomyelitis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFECTIVE AGENT;
BETA-TRICALCIUM PHOSPHATE;
BIOMATERIAL;
BONE PROSTHESIS;
CALCIUM PHOSPHATE;
CERAMICS;
CIPROFLOXACIN;
LACTIDE-CAPROLACTONE COPOLYMER;
POLYESTER;
RIFAMPICIN;
ABSORPTION;
ANTIBIOTIC RESISTANCE;
BONE;
BONE PROSTHESIS;
CERAMICS;
CHEMISTRY;
DRUG DELIVERY SYSTEM;
DRUG EFFECTS;
HYDROLYSIS;
MATERIALS TESTING;
MOLECULAR WEIGHT;
OSTEOMYELITIS;
PSEUDOMONAS AERUGINOSA;
TEMPERATURE;
TIME;
ABSORPTION;
ANTI-BACTERIAL AGENTS;
BIOCOMPATIBLE MATERIALS;
BONE AND BONES;
BONE SUBSTITUTES;
CALCIUM PHOSPHATES;
CERAMICS;
CIPROFLOXACIN;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE, BACTERIAL;
HYDROLYSIS;
MATERIALS TESTING;
MOLECULAR WEIGHT;
OSTEOMYELITIS;
POLYESTERS;
PSEUDOMONAS AERUGINOSA;
RIFAMPIN;
TEMPERATURE;
TIME FACTORS;
|
EID: 84896418589
PISSN: None
EISSN: 21592535
Source Type: Journal
DOI: 10.4161/biom.22793 Document Type: Article |
Times cited : (9)
|
References (0)
|